iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 855

Identifiers

  • Canonical SMILES: 
    CCN(Cc1ccc(cc1)C#N)[C@H]1C[C@@H]2N(C1)C(=O)N(C2=O)c1cc(Cl)cc(Cl)c1
  • InChi: 
    InChI=1S/C22H20Cl2N4O2/c1-2-26(12-15-5-3-14(11-25)4-6-15)19-10-20-21(29)28(22(30)27(20)13-19)18-8-16(23)7-17(24)9-18/h3-9,19-20H,2,10,12-13H2,1H3/t19-,20-/m0/s1
  • InChiKey: 
    YFMNNQNVKODXCQ-PMACEKPBSA-N

External links


168318053

External search

Bibliography (1)

Publication Name
Potin D, Launay M, Nicolai E, Fabreguette M, Malabre P, Caussade F, Besse D, Skala S, Stetsko DK, Todderud G, Beno BR, Cheney DL, Chang CJ, Sheriff S, Hollenbaugh DL, Barrish JC, Iwanowicz EJ, Suchard SJ, Dhar TG. . De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold. Bioorganic & medicinal chemistry letters. 17

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
0 1 0 0

Targets

PPI family Best activity Diseases MMoA
LFA / ICAM 6.14 immune system disease Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 442.10 g/mol
HBA 6
HBD 0
HBA + HBD 6
AlogP 3.98
TPSA 67.65
RB 5
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 1 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
15686933 17 ITAL
P20701
Cellular assay hsb-2 cell adhesion assay pIC50 (half maximal inhibitory concentration, -log10) 6.14
Ta Structure Name Drugbank ID
0.6485 BMS-564929 DB07286
0.6194 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE DB08087
0.5450 Degarelix DB06699
0.5380 METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE DB07328
0.5325 Mosapramine DB13676
0.5307 Fedovapagon DB11734
0.5248 Olcegepant DB04869
0.5108 GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE DB07813
0.5050 Eribaxaban DB06920
0.5035 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide DB06878
0.5035 D-leucyl-N-(3-chlorobenzyl)-L-prolinamide DB06911
0.5031 Fluspirilene DB04842
0.5028 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE DB07974
0.4971 Ombitasvir DB09296
0.4968 Balicatib DB12239